Rheoxtech Appoints David W.J. Smith As President

Wednesday, May 3, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

CHICAGO, May 3, 2017 /PRNewswire/ --Chicago based Rheoxtech LLC has appointed David W.J. Smith

as its first President. David has 30 years' experience in founding, developing and providing successful exits for medical device businesses and their investors. He originally started his career in the UK, before moving to the US and immersing himself
in medical device startup companies in the San Francisco Bay Area. His most recent notable success was as the founding CEO of Tenaxis Medical Inc, a surgical sealant business. He coordinated the development, regulatory approvals and product commercialization for the company. He assisted in raising $22M for the company over 4 different funding series. Tenaxis Medical was acquired by The Medicines Company in 2014 for a payment of up to $178M. Beyond this, David has deep and broad experience in the fields of interventional cardiology, cardiac and vascular surgery, general surgery and ophthalmology.

Rheoxtech was founded by cardiac surgeon Neil J. Thomas MD and serial entrepreneur Gintaras Vaisnys. It is building on the pioneering work of Dr Thomas, a longtime proponent of controlling cardiac oxygen re-exposure as part of the protection of the heart during surgery, particularly for patients that are hemodynamically unstable and those in cardiogenic shock.

Mr. Vaisnys commented, "We are delighted to attract someone of David's caliber to this critical role. He has exactly the right blend of project management, fund raising and business development experience we were seeking to drive outstanding shareholder returns."

Rheoxtech LLC is a closely held private company, committed to the development of devices for protected reperfusion in percutaneous coronary intervention (PCI) and cardiac surgery.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/rheoxtech-appoints-david-wj-smith-as-president-300450477.html

SOURCE Rheoxtech LLC



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Find a Doctor
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook